Company / PP&E (Net)
Lexaria Bioscience Corp. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$228.1K
FY2025
5-year range
$228.1K / $368.2K
FY2021-FY2025
Trend
-10.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 9 years, ranging from $1,856 in FY2017 to $591,263 in FY2019.
Based on SEC 10-K filings.
$228,129 in FY2025 with a 5-year CAGR of -13.9%.
Declined from $254,143 to $228,129 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -10.2%
- 5-Year CAGR
- -13.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -13.9%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 10.4% year-over-year.
- Peak pp&e (net) was recorded in FY2019.
- Lowest pp&e (net) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $228.1K | -10.4% |
| FY2024 | $254.7K | +0.2% |
| FY2023 | $254.1K | -19.4% |
| FY2022 | $315.5K | -14.3% |
| FY2021 | $368.2K | -23.8% |
| FY2020 | $483.4K | -18.3% |
| FY2019 | $591.3K | +31756.8% |
| FY2017 | $1.9K | -25.0% |
| FY2016 | $2.5K | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026